Johnson & Johnson Reports 2019 First-Quarter Results:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Johnson & Johnson (JNJ) PT Raised to $140 at Stifel
April 17, 2019 8:43 AM EDTStifel analyst Rick Wise raised the price target on Johnson & Johnson (NYSE: JNJ) to $140.00 (from $135.00) while maintaining a Hold rating. 1Q19 sales and EPS outperformed expectations and management raised operational sales growth and underlying EPS outlooks. The results were buoyed by better-thanexpected Pharmaceutical and... More
Johnson & Johnson (JNJ) PT Raised to $147 at Raymond James
April 17, 2019 7:42 AM EDTRaymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $147.00 (from $145.00) while maintaining a Outperform rating.
growth was still much better than expected, which gives us more confidence in our estimates... MoreJohnson & Johnson (JNJ) PT Raised to $157 at BMO Capital
April 17, 2019 6:56 AM EDTBMO Capital analyst Joanne Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $157.00 (from $154.00) while maintaining a Outperform rating.
Staying On Course in Its Transition Year
tightening EPS to $8.53-$8.63 from $8.50-$8.65
... MoreJohnson & Johnson (JNJ) PT Raised to $150 at RBC Capital
April 17, 2019 6:37 AM EDTRBC Capital analyst Brandon Henry raised the price target on Johnson & Johnson (NYSE: JNJ) to $150.00 (from $144.00) while maintaining a Outperform rating.
Strong start to 2019; revised guidance appears conservative... MoreJohnson & Johnson (JNJ) Tops Q1 EPS by 6c
April 16, 2019 6:41 AM EDT(Updated - April 16, 2019 6:43 AM EDT)
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.10, $0.06 better than the analyst estimate of $2.04. Revenue for the quarter came in at $20.02 billion versus the consensus estimate of $19.61 billion.
GUIDANCE:
Johnson & Johnson sees FY2019 EPS of... More
